乳腺癌在患有初级卵巢缺陷的妇女中增加
Kristina Allen-Brady1, Barry Moore2, Lauren E Verrilli3,4
1Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT 84108, USA.
The Journal of clinical endocrinology and metabolism
|July 12, 2024
概括
患有原发性卵巢缺陷 (POI) 的女性患乳腺癌和卵巢癌的风险更高. 他们的亲属也显示乳腺癌,结肠癌和前列腺癌的风险增加,这表明他们有共同的遗传因素.
科学领域:
- 遗传学和基因组学 遗传学和基因组学
- 在瘤学瘤学.
- 生殖内分泌学 生殖内分泌学
背景情况:
- DNA损伤/修复基因的变异与原发性卵巢缺陷 (POI) 和癌症易感性有关.
- 一个假设提出了被诊断为POI的妇女及其家属的潜在癌症风险增加.
研究的目的:
- 调查被诊断患有原发性卵巢缺陷 (POI) 的女性癌症风险.
- 评估POI妇女亲属的癌症风险.
- 探索POI和癌症的潜在共同遗传基础.
主要方法:
- 一项基于人口的病例控制研究使用从1995年到2022年的健康记录进行.
- 确定了POI (n=613) 的妇女,并使用犹他州人口数据库将她们的亲属联系起来.
- 从犹他州癌症登记处获得癌症诊断,并将相对风险与人口率进行比较. 全基因组测序是在一个子集上进行的.
主要成果:
- 患有POI的女性表现出患乳腺癌的风险增加 (OR,2.20) 和卵巢癌的名义上显著增加.
- 二级亲属显示乳腺癌 (OR,1.28) 和结肠癌 (OR,1.50) 的风险增加.
- 第一个 (OR,1.64),第二个 (OR,1.54) 和第三级亲属 (OR,1.33) 的前列腺癌风险都较高.
结论:
- 研究结果表明,一种共同的遗传倾向将原发性卵巢缺陷 (POI) 与生殖癌联系在一起.
- 开发工具来预测POI妇女的癌症风险是有必要的.
- 对POI妇女的激素替代疗法风险进行遗传咨询可能是有益的.
相关概念视频
Oogenesis
63.6K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.6K
Disorders of the Female Reproductive System
347
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
347
Infertility in Females
289
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
289
Ovarian Cycle
1.1K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.1K
Hormonal Control of the Ovarian Cycle
461
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
461
Cancer Survival Analysis
340
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
340


